Evidence map›Paper›PMID 29029265›Full record

ArticleThe Journal of antimicrobial chemotherapy2018

Preclinical testing of a broad-spectrum antimicrobial endotracheal tube coated with an innate immune synthetic mimic.

Marjan M Hashemi, John Rovig, Jordan Bateman, Brett S Holden, Tomasz Modelzelewski, Iliana Gueorguieva, Martin von Dyck, Ronald Bracken, Carl Genberg, Shenglou Deng and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Hydrogel applications: a promising frontier in pneumonia therapy.Frontiers in bioengineering and biotechnology · 2025
    Review
  6. Article
  7. Investigating the Effectiveness of Ceragenins againstInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Antimicrobial Coating: Tracheal Tube Application.International journal of nanomedicine · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Marjan M HashemiDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
John RovigDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
Jordan BatemanDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
Brett S HoldenDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
Tomasz ModelzelewskiHydromer, Inc, Branchburg, NJ, USA.
Iliana GueorguievaHydromer, Inc, Branchburg, NJ, USA.
Martin von DyckHydromer, Inc, Branchburg, NJ, USA.
Ronald BrackenN8 Medical, Inc, Columbus, OH, USA.
Carl GenbergN8 Medical, Inc, Columbus, OH, USA.
Shenglou DengDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
Paul B SavageDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
Brigham Young University · USHydromer (United States) · USN8 Medical (United States) · US

Funding

Development of a Novel Antimicrobial Foley Catheter to Prevent CAUTIsR41DK102237 · NIDDK · HYDROMER, INC. · PI SAVAGE, PAUL B, VON DYCK, MARTIN · 2014 to 2014
$224k
NIDDK NIH HHS R41 DK102237
6 · The paper itself

Abstract

backgroundEndotracheal tubes provide an abiotic surface on which bacteria and fungi form biofilms, and the release of endotoxins and planktonic organisms can cause damaging inflammation and infections.

objectivesCeragenins are small molecule mimics of antimicrobial peptides with broad-spectrum antibacterial and antifungal activity, and a ceragenin may be used to provide antimicrobial protection to the abiotic surface of an endotracheal tube.

methodsA hydrogel film, containing CSA-131, was generated on endotracheal tubes. Elution of CSA-131 was quantified in drip-flow and static systems, antifungal and antibacterial activity was measured with repeated inoculation in growth media, biofilm formation was observed through electron microscopy, safety was determined by intubation of pigs with coated and uncoated endotracheal tubes.

resultsOptimized coatings containing CSA-131 provided controlled elution of CSA-131, with concentrations released of less than 1 μg/mL. The eluting ceragenin prevented fungal and bacterial colonization of coated endotracheal tubes for extended periods, while uncoated tubes were colonized by bacteria and fungi. Coated tubes were well tolerated in intubated pigs.

conclusionsThin films containing CSA-131 provide protection against microbial colonization of endotracheal tubes. This protection prevents fungal and bacterial biofilm formation on the tubes and reduces endotoxin associated with tubes. This coating is well suited for decreasing the adverse effects of intubation associated with infection and inflammation.

Indexed as

Anti-Infective AgentsBacteriaBiofilmsCandida albicansCoated Materials, BiocompatibleHumansHydrogelsIntubation, IntratrachealKlebsiella pneumoniaePneumonia, Ventilator-AssociatedPseudomonas aeruginosaRespiration, ArtificialSteroidsAnti-Infective Agentsceragenin CSA-131Coated Materials, BiocompatibleHydrogelsSteroids

Identifiers

PMID29029265
PMCPMC5890737
OpenAlexW2761554629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.